Option Care Health, Inc. (OPCH) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Care Facilities secteur d'activité. Le siège social de l'entreprise est situé à Bannockburn, IL, United States. Le PDG actuel est John C. Rademacher.
OPCH a date d'introduction en bourse 1996-08-15, 8,000 employés à temps plein, cotée sur le NASDAQ Global Select, une capitalisation boursière de $4.36B.
Option Care Health, Inc. is a leading provider of home and alternate site infusion services throughout the United States, headquartered in Bannockburn, Illinois. The company delivers a comprehensive range of specialized therapies including anti-infective treatments, home infusion services for heart failure, parenteral and enteral nutrition support, immunoglobulin therapies, and treatments for chronic inflammatory disorders such as Crohn's disease, rheumatoid arthritis, and ulcerative colitis. Additionally, Option Care Health provides therapies for neurological disorders, bleeding disorders, high-risk pregnancy management, and other infusion-based treatments including pain management, chemotherapy, and respiratory medications, supported by integrated nursing services.
